Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)

v3.25.1
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Series A Convertible Preferred Stock [Member]
Beginning balance, value at Dec. 31, 2023 $ 0   $ 101,175,117 $ (120,806,138) $ (19,631,021) $ 0
Beginning balance, shares at Dec. 31, 2023 1,291         0
Issuance of common stock for exercise of pre-funded warrants   1 1
Issuance of common stock for exercise of pre-funded warrants, shares 93          
Issuance of common stock for exercise of Series A warrants   17,352,653 17,352,653
Issuance of common stock for exercise of Series A warrants, shares 14,839          
Proceeds received for exercise of buydown warrants   3,500 3,500
Proceeds received for exercise of buydown warrants, shares 10          
Common stock issued for conversion of convertible notes   7,395,907 7,395,907
Common stock issued for conversion of convertible notes, shares 4,971          
Conversion of Convertible Notes   24,716,118 24,716,118
Conversion of Convertible Notes, shares           24,698
Conversion of preferred stock for common stock  
Conversion of preferred stock for common stock, shares 2,150         (2,288)
Issuance of common stock for exercise of Series B Warrants  
Issuance of common stock for exercise of Series B Warrants, shares 88          
Stock-based compensation   (1,922) (1,922)
Shares Issued Due to Rounding  
Shares Issued Due to Rounding, shares 1          
Net loss   (26,048,044) (26,048,044)
Ending balance, value at Mar. 31, 2024 $ 0   150,641,374 (146,854,182) 3,787,192 $ 0
Ending balance, shares at Mar. 31, 2024 23,433         22,410
Beginning balance, value at Dec. 31, 2024 $ 7 $ 0 166,357,201 (166,316,447) 40,761  
Beginning balance, shares at Dec. 31, 2024 630,865          
Beginning balance, shares at Dec. 31, 2024   0        
Issuance of common stock for exercises of pre-funded warrants $ 14 (14)  
Issuance of common stock for exercises of pre-funded warrants, shares 1,408,927          
Issuance of common stock from the At the Money offering, net of issuance costs of $320,867 $ 17 8,846,744 8,846,761  
Issuance of common stock from the At the Money offering, net of issuance costs, shares 1,764,113          
Issuance of common stock and pre-funded warrants, net of issuance costs of $1,296,118 $ 4 10,703,878 10,703,882  
Issuance of common stock and pre-funded warrants, net of issuance costs, shares 430,000          
Stock-based compensation 10,052 10,052  
Repurchases of common stock for Treasury Stock $ (401,806) (401,806)  
Repurchases of common stock for Treasury Stock, shares (383,081) 383,081        
Net loss (2,460,430) (2,460,430)  
Ending balance, value at Mar. 31, 2025 $ 42 $ (401,806) $ 185,917,861 $ (168,776,877) $ 16,739,220  
Ending balance, shares at Mar. 31, 2025 3,850,824          
Ending balance, shares at Mar. 31, 2025   383,081